S100A8 and S100A9 form a heterodimer (S100A8/A9 or calprotectin) and act as a proinflammatory mediator that is associated with acute and chronic inflammation, cancer cell metastasis, and tumorigenesis [85, 86]. Here, S100A9 is linked to cancer.